KR20230007680A - Skin Moisturizing and Nutrition Cream Cosmetic Composition Containing Bee Veom Extract And Vegetable Placenta - Google Patents
Skin Moisturizing and Nutrition Cream Cosmetic Composition Containing Bee Veom Extract And Vegetable Placenta Download PDFInfo
- Publication number
- KR20230007680A KR20230007680A KR1020210088312A KR20210088312A KR20230007680A KR 20230007680 A KR20230007680 A KR 20230007680A KR 1020210088312 A KR1020210088312 A KR 1020210088312A KR 20210088312 A KR20210088312 A KR 20210088312A KR 20230007680 A KR20230007680 A KR 20230007680A
- Authority
- KR
- South Korea
- Prior art keywords
- oil
- water
- moisturizing
- skin
- type
- Prior art date
Links
- 239000006071 cream Substances 0.000 title claims abstract description 52
- 239000000284 extract Substances 0.000 title claims abstract description 37
- 210000002826 placenta Anatomy 0.000 title claims abstract description 25
- 235000013311 vegetables Nutrition 0.000 title claims abstract description 15
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 12
- 230000035764 nutrition Effects 0.000 title claims abstract description 8
- 230000003020 moisturizing effect Effects 0.000 title claims description 33
- 239000000203 mixture Substances 0.000 title claims description 31
- 239000002537 cosmetic Substances 0.000 title claims description 22
- 239000003921 oil Substances 0.000 claims abstract description 81
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 59
- 239000003659 bee venom Substances 0.000 claims abstract description 31
- 239000010775 animal oil Substances 0.000 claims abstract description 23
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 19
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 19
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 18
- 235000019198 oils Nutrition 0.000 claims description 80
- 239000000839 emulsion Substances 0.000 claims description 29
- 239000012071 phase Substances 0.000 claims description 27
- 239000008346 aqueous phase Substances 0.000 claims description 21
- 239000003381 stabilizer Substances 0.000 claims description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 12
- 239000008158 vegetable oil Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 10
- 235000015097 nutrients Nutrition 0.000 claims description 10
- 239000008213 purified water Substances 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 235000008935 nutritious Nutrition 0.000 claims description 7
- 239000001993 wax Substances 0.000 claims description 7
- 239000004166 Lanolin Substances 0.000 claims description 6
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 6
- 239000010776 emu oil Substances 0.000 claims description 6
- 239000008387 emulsifying waxe Substances 0.000 claims description 6
- 235000019388 lanolin Nutrition 0.000 claims description 6
- 229940039717 lanolin Drugs 0.000 claims description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 6
- 235000008390 olive oil Nutrition 0.000 claims description 6
- 239000004006 olive oil Substances 0.000 claims description 6
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 abstract description 26
- 230000000694 effects Effects 0.000 abstract description 15
- 238000004945 emulsification Methods 0.000 abstract description 11
- 239000005445 natural material Substances 0.000 abstract description 6
- 150000004665 fatty acids Chemical class 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 230000009759 skin aging Effects 0.000 abstract description 4
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 3
- 229930195729 fatty acid Natural products 0.000 abstract description 3
- 239000000194 fatty acid Substances 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 230000037384 skin absorption Effects 0.000 abstract description 2
- 231100000274 skin absorption Toxicity 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 50
- 238000011156 evaluation Methods 0.000 description 8
- 235000010469 Glycine max Nutrition 0.000 description 6
- 229940057917 medium chain triglycerides Drugs 0.000 description 6
- 229940015975 1,2-hexanediol Drugs 0.000 description 5
- 101000761020 Dinoponera quadriceps Poneritoxin Proteins 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 5
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 5
- 230000037303 wrinkles Effects 0.000 description 5
- 229920002385 Sodium hyaluronate Polymers 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000002329 infrared spectrum Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 229940010747 sodium hyaluronate Drugs 0.000 description 4
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- -1 secapine Chemical compound 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 description 2
- 241000257303 Hymenoptera Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 229940116978 human epidermal growth factor Drugs 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- GCJYUUCHJZQFLE-JQWIXIFHSA-N (2s)-2-[[2-[[(2s)-2-aminopropanoyl]amino]acetyl]amino]-n-[2-[2-(1h-imidazol-5-yl)ethylamino]acetyl]pentanediamide Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)NC(=O)CNCCC1=CN=CN1 GCJYUUCHJZQFLE-JQWIXIFHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 101710126338 Apamin Proteins 0.000 description 1
- 241000256837 Apidae Species 0.000 description 1
- XWVGIRQKQVRGJG-UHFFFAOYSA-N C(C)C(O)(C(O)CO)CCCCCC.OCC(O)CO Chemical compound C(C)C(O)(C(O)CO)CCCCCC.OCC(O)CO XWVGIRQKQVRGJG-UHFFFAOYSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 239000009141 Houttuynia cordata plant extract Substances 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 108010036176 Melitten Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 241000219295 Portulaca Species 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 241000270708 Testudinidae Species 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000001140 aloe barbadensis leaf extract Substances 0.000 description 1
- 229940069638 aloe vera leaf extract Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940059958 centella asiatica extract Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000037310 combination skin Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- NLMOQNHZOQGLSZ-UHFFFAOYSA-N heptyl undec-10-enoate Chemical compound CCCCCCCOC(=O)CCCCCCCCC=C NLMOQNHZOQGLSZ-UHFFFAOYSA-N 0.000 description 1
- 229940086561 heptyl undecylenate Drugs 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 108010077372 mast cell degranulating peptide Proteins 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QMBRLNFAEHGOLY-UHFFFAOYSA-N mcd peptide Chemical compound N1C(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)C(C)CC)CSSCC(C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(N)=O)C(N)=O)NC(=O)C(C(C)CC)NC(=O)C(CCCCN)NC(=O)C(CCCNC(N)=N)NC(=O)C(NC(=O)C(C(C)CC)NC(=O)C(CC2N=CN=C2)NC(=O)C2CCCN2C(=O)C(CCCCN)NC(=O)C(C(C)CC)NC(=O)C(C(C)C)NC2=O)CSSCC1C(=O)NC(CCCCN)C(=O)NC(CCCNC(N)=N)C(=O)NC2CC1C=NC=N1 QMBRLNFAEHGOLY-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- VDXZNPDIRNWWCW-JFTDCZMZSA-N melittin Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-JFTDCZMZSA-N 0.000 description 1
- YVIIHEKJCKCXOB-STYWVVQQSA-N molport-023-276-178 Chemical compound C([C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CSSC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(N[C@@H](CSSC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)=O)CC(C)C)[C@@H](C)O)C(N)=O)C1=CNC=N1 YVIIHEKJCKCXOB-STYWVVQQSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000007903 penetration ability Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 108010035114 procamine Proteins 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 봉독 추출물 및 식물성 플라센타를 포함하는 보습 영양 크림 화장료 조성물에 관한 것이다.The present invention relates to a moisturizing and nourishing cream cosmetic composition comprising bee venom extract and plant placenta.
봉독(Bee Venom)은 약 40여 가지의 활성 펩타이드로 구성된 꿀벌의 방어물질로서 유해물질 저항력이 탁월하여 주름관리, 진정과 피지 발생을 낮춰주는 천연 성분으로 알려져 있다. 플라센타(placenta)는 태반으로도 알려져 있으며 다양한 성장인자(growth factor)를 포함하므로 상처복원력이 뛰어나며 콜라겐을 젊은 콜라겐으로 대체시켜주는 기능을 가지고 있을 뿐 아니라 유분이 많이 함유되어 수분과 피지가 건조해 지는 현상을 막을 수 있는 효과가 있다.Bee venom is a defense substance of bees composed of about 40 active peptides. It has excellent resistance to harmful substances and is known as a natural ingredient that manages wrinkles, soothes and reduces sebum production. Placenta, also known as placenta, has excellent wound resilience as it contains various growth factors, and has the function of replacing collagen with young collagen. It has the effect of preventing the phenomenon.
상기 봉독과 플라센타는 정체 추출물 상태로 화장료에 포함되어 노화를 예방하고 피부를 복원하며 수분을 유지하며 혈액순환을 촉진시켜 노폐물의 제거를 돕고 영양성분을 보급해 진피조직의 기능을 향상시키는 용도로 사용되고 있다. The bee venom and placenta are included in cosmetics as stagnant extracts to prevent aging, restore skin, maintain moisture, promote blood circulation to help remove wastes, and are used to improve the function of dermal tissue by supplying nutrients. there is.
화장료 조성물 중 스킨을 제외한 에센스, 로션, 크림 성상은 유화시킨 에멀젼을 주로 사용한다. 상기 에멀젼은 오일이 내부에 있고 물이 외부에 있는 Oil in Water(O/W) 타입과 반대로 물이 안에 있고 오일이 밖에 있는 Water in Oil (W/O) 타입으로 분류되며 그 중 Oil in Water(O/W) 타입은 발림성이 좋아 여러 개를 덧바르기도 쉽고 다른 것과의 상용성도 우수한 장점이 있다.Among cosmetic compositions, emulsions emulsified are mainly used for essences, lotions, and creams except skin. The emulsion is classified into a Water in Oil (W / O) type in which water is inside and oil is outside, as opposed to an Oil in Water (O / W) type in which oil is inside and water is outside, and among them, Oil in Water ( O/W) type has good spreadability, so it is easy to apply multiple layers and has excellent compatibility with others.
화장료 조성물에 포함되는 수상의 유효성분은 유화 에멀젼에서 유상성분과 혼합되되 그 표면에 위치하거나 그 내부에 위치하게 되며 상기 유상성분은 피부 발림시 유효성분을 피부내로 침투시키는 역할을 하게 된다. 상기 유효성분의 피부침투성과 그 효능을 증대시키기 위하여 인공 화학물질을 사용하기도 하는데 화장료 조성물의 점도를 변화시켜 발림성이 저하되거나 피부를 자극시켜 피부트러블을 유도하는 문제점이 있었다. The active ingredient of the aqueous phase included in the cosmetic composition is mixed with the oily ingredient in the emulsified emulsion and is located on the surface or inside it, and the oily ingredient plays a role in penetrating the active ingredient into the skin when applied to the skin. In order to increase the skin penetration and efficacy of the active ingredient, artificial chemicals are sometimes used, but there is a problem of reducing the application property by changing the viscosity of the cosmetic composition or inducing skin trouble by stimulating the skin.
본 명세서에서 언급된 특허문헌 및 참고문헌은 각각의 문헌이 참조에 의해 개별적이고 명확하게 특정된 것과 동일한 정도로 본 명세서에 참조로 삽입된다. The patents and references mentioned herein are incorporated herein by reference to the same extent as if each document were individually and expressly specified by reference.
본 발명은 상기 문제점을 해결하기 위하여 봉독 및 플라센타 성분을 포함하여 피부 보호 효과를 가지면서도 피부자극이 없는 천연물질을 이용하여 발림성이 우수하고 피부트러블을 유도하지 않는 보습 영양 크림 화장료 조성물을 제공하는 것을 목적으로 한다.In order to solve the above problems, the present invention provides a moisturizing and nutritious cream cosmetic composition that has excellent application properties and does not induce skin trouble by using natural substances that have skin protection effects and do not cause skin irritation, including bee venom and placenta components. The purpose.
본 발명의 다른 목적 및 기술적 특징은 이하의 발명의 상세한 설명, 청구의 범위 및 도면에 의해 보다 구체적으로 제시된다. Other objects and technical features of the present invention are presented more specifically by the following detailed description, claims and drawings.
본 발명은 봉독 추출물(Bee Venom Extract), 식물성 플라센타(Vegetable Placenta), sh-올리고펩타이드-1(sh-Oligopeptide-1) 및 히알루론산(Hyaluronic acid)을 포함하는 Oil in Water(O/W) 타입-보습 영양 크림 화장료 조성물을 제공한다. The present invention is an Oil in Water (O/W) type containing Bee Venom Extract, Vegetable Placenta, sh-Oligopeptide-1, and Hyaluronic acid. -Provides a moisturizing and nourishing cream cosmetic composition.
상기 Oil in Water(O/W) 타입-보습 영양크림은 수상성분과 유상성분이 2.7 내지 3.0:1의 중량비로 혼합되어 제조되되, 봉독 추출물, 식물성 플라센타, sh-올리고펩타이드-1, 히알루론산, 정제수, 글리세린, 및 부틸렌글리콜로 구성되는 수상성분과; 동물성 오일인 마유, 에뮤오일, 및 라놀린과 식물성 오일인 렉스필 오일 및 MCT 오일로 구성되는 유상성분과; 이멀시파잉 왁스,세테아릴알코올, 올리브유 왁스 및 에틸헥산로 구성되는 유화안정제가 혼합되어 제조된다. The Oil in Water (O/W) type-moisturizing nourishing cream is prepared by mixing water phase components and oil phase components at a weight ratio of 2.7 to 3.0: 1, bee venom extract, vegetable placenta, sh-oligopeptide-1, hyaluronic acid, an aqueous phase component composed of purified water, glycerin, and butylene glycol; An oily component composed of animal oils such as horse oil, emu oil, and lanolin, and vegetable oils such as Rexpil Oil and MCT Oil; It is prepared by mixing emulsion stabilizers composed of emulsifying wax, cetearyl alcohol, olive oil wax and ethylhexane.
상기 수상성분은 봉독 추출물, 식물성 플라센타, sh-올리고펩타이드-1 및 히알루론산이 1:1:1:1로 포함되며 상기 유상성분은 동물성 오일과 식물성 오일이 1.8 내지 2.2:1의 중량비로 포함되며 상기 수상성분의 봉독 추출물, 식물성 플라센타, sh-올리고펩타이드-1 및 히알루론산과 상기 유상 성분의 동물성 오일은 0.6 내지 1:1의 중량비로 포함된 것을 특징으로 한다.The aqueous phase component includes bee venom extract, vegetable placenta, sh-oligopeptide-1, and hyaluronic acid in a ratio of 1:1:1:1, and the oil phase component includes animal oil and vegetable oil in a weight ratio of 1.8 to 2.2:1. It is characterized in that the bee venom extract, vegetable placenta, sh-oligopeptide-1 and hyaluronic acid of the aqueous phase component and the animal oil of the oil phase component are included in a weight ratio of 0.6 to 1:1.
또한 본 발명의 Oil in Water(O/W) 타입-보습 영양크림은 점도가 21000 내지 24000dPa·S이며 도포 12시간 후 수분함량이 50 내지 55%인 것을 특징으로 한다.In addition, the Oil in Water (O/W) type moisturizing nutrient cream of the present invention has a viscosity of 21000 to 24000 dPa·S and a moisture content of 50 to 55% after 12 hours of application.
본 발명의 Oil in Water(O/W) 타입-보습 영양크림은 유효성분으로서 봉독 추출물(Bee Venom Extract), 식물성 플라센타(Vegetable Placenta), sh-올리고펩타이드-1(sh-Oligopeptide-1) 및 히알루론산(Hyaluronic acid)을 포함하되 천연물질을 주원료로 유화에 최적화되어 있으며 피부조직을 이루는 지방산과 구조가 유사한 동물성 오일을 포함하는 특징이 있다. The Oil in Water (O/W) type moisturizing nutrient cream of the present invention contains Bee Venom Extract, Vegetable Placenta, sh-Oligopeptide-1 and hyaluronic acid as active ingredients. It includes hyaluronic acid, but it is optimized for emulsification with natural substances as the main raw material, and is characterized by containing animal oils that are similar in structure to fatty acids constituting skin tissue.
따라서 본 발명의 Oil in Water(O/W) 타입-보습 영양크림은 유화가 최적화되어 발림성이 우수할 뿐 아니라 천연물질을 사용하므로 피부자극이 없고 동물성 오일이 포함되어 유효성분의 피부 흡수가 촉진되므로 피부노화 방지, 피부 영양 공급, 피부 복원, 피부 수분의 유지 효과가 탁월한 장점이 있다. Therefore, the Oil in Water (O/W) type-moisturizing nutrient cream of the present invention has optimized emulsification and excellent spreadability, and uses natural substances so there is no skin irritation and contains animal oil to promote skin absorption of active ingredients. It has outstanding advantages in preventing skin aging, supplying skin nutrients, restoring skin, and maintaining skin moisture.
도 1은 본 발명의 적외선 스펙트럼 분석결과를 보여준다.
도 2는 본 발명의 점도측정 결과를 보여준다.
도 3은 본 발명의 수분보습평가 결과를 보여준다.
도 4는 본 발명의 Oil in Water(O/W) 타입-보습 영양 크림 화장료 조성물을 제조한 결과를 보여준다. 1 shows the results of infrared spectrum analysis of the present invention.
Figure 2 shows the results of measuring the viscosity of the present invention.
Figure 3 shows the moisture moisturizing evaluation results of the present invention.
Figure 4 shows the results of preparing the oil in water (O / W) type-moisturizing nutritional cream cosmetic composition of the present invention.
본 발명은 봉독 추출물(Bee Venom Extract), 식물성 플라센타(Vegetable Placenta), sh-올리고펩타이드-1(sh-Oligopeptide-1) 및 히알루론산(Hyaluronic acid)을 포함하는 Oil in Water(O/W) 타입-보습 영양 크림 화장료 조성물을 제공한다.The present invention is an Oil in Water (O/W) type containing Bee Venom Extract, Vegetable Placenta, sh-Oligopeptide-1, and Hyaluronic acid. -Provides a moisturizing and nourishing cream cosmetic composition.
상기 봉독 추출물은 꿀벌 중 일벌의 독낭에서 분비하는 분비물을 정제한 것으로 멜리틴, 아파민, 세카핀, 도파민, 아돌라핀, 프로테아제 억제인자, 엠시디 펩타이드, 프로카민, 히스타민, 및 히알루다아제를 포함하는 활성 펩타이드가 포함될 수 있다. 상기 복독 추출물은 공인인증기관의 세포독성 및 피부자극테스트를 통과한 화장품 조성물 용도의 봉독 추출물을 사용하는 것이 바람직하다. 상기 봉독 추출물은 유해물질 저항력이 탁월하여 주름관리, 피부 진정과 피지 발생 억제 효과가 있다. The bee venom extract is a purified secretion secreted from the venom of worker bees among honey bees, and contains melittin, apamin, secapine, dopamine, adolafin, protease inhibitor, MCD peptide, procamine, histamine, and hyaludase Active peptides may be included. It is preferable to use bee venom extracts for use in cosmetic compositions that have passed the cytotoxicity and skin irritation tests of accredited certification institutions as the bee venom extract. The bee venom extract has excellent resistance to harmful substances and has effects of wrinkle care, skin soothing, and suppression of sebum production.
상기 식물성 플라센타는 식물로부터 추출한 태반 추출물을 의미하며 바람직하게는 콩으로부터 추출한 피토플라센타(Phytoplacenta) 추출물을 의미한다. 상기 피토플라센타 추출물은 발아대두로부터 추출할 수 있으며 아미노산과 세포활성인자가 풍부하여 피부세포재생 촉진 및 영양공급에 효과가 있어 피부주름개선 및 피부노화방지용 조성물로 사용될 수 있다. The plant placenta refers to a placenta extract extracted from a plant, and preferably refers to a phytoplacenta extract extracted from soybeans. The phytoplacenta extract can be extracted from germinated soybeans and is rich in amino acids and cell activators, so it is effective in promoting skin cell regeneration and supplying nutrients, so it can be used as a composition for improving skin wrinkles and preventing skin aging.
상기 sh-올리고펩타이드-1은 발효된 단일사슬 인간재조합 펩타이드 성분으로 합성 인간 피부 상피세포 성장인자(Synthetic Human Epidermal Growth Factor, sh_EGF)에서 유래한다. 상기 sh-올리고펩타이드-1은 피부 장벽을 탄탄하게 채워 강화시키고 피부 노화로 인해 생긴 주름에 탄력을 부여하는데 관여하며 피부 주기의 순환을 촉진하여 새로운 피부층으로의 전환을 촉진하는 효과가 있다.The sh-oligopeptide-1 is a fermented single-chain human recombinant peptide component derived from synthetic human epidermal growth factor (sh_EGF). The sh-oligopeptide-1 is effective in firmly filling and strengthening the skin barrier, being involved in providing elasticity to wrinkles caused by skin aging, and promoting the conversion to a new skin layer by promoting the circulation of the skin cycle.
상기 히알루론산은 피부에 주로 존재하는 생체 합성 천연 물질로서 피부 보습작용을 한다. 본 발명의 히알루론산은 분자량(Mw) 10000미만의 올리고-히알루론산일 수 있으며 피부 컨디셔닝 용도로 제조된 것을 사용하는 것이 바람직하다.The hyaluronic acid is a biosynthetic natural substance mainly present in the skin and has a moisturizing effect on the skin. The hyaluronic acid of the present invention may be an oligo-hyaluronic acid having a molecular weight (Mw) of less than 10000, and it is preferable to use one prepared for skin conditioning purposes.
상기 Oil in Water(O/W) 타입은 유화를 통해 형성된 에멀젼 타입을 의미하며 오일이 내부에 있고 물이 외부에 있는 구조를 가진다. 상기 Oil in Water(O/W) 타입은 스킨을 제외한 에센스, 로션, 크림 성상에 사용되며 발림성 및 상용성도 우수한 장점이 있다.The Oil in Water (O/W) type means an emulsion type formed through emulsification and has a structure in which oil is inside and water is outside. The Oil in Water (O/W) type is used for essence, lotion, and cream properties excluding skin, and has excellent application properties and compatibility.
본 발명의 Oil in Water(O/W) 타입-보습 영양크림은 수상성분과 유상성분이 유화되어 제조되는 것을 특징으로 하며 유효성분을 수용성 용매에 용해시켜 수상성분을 제조하는 제 1 단계; 유상성분을 제조하는 제 2 단계; 상기 수상성분, 유상성분 및 유화안정화제를 혼합하는 제 3 단계; 및 상기 혼합된 수상성분, 유상성분 및 유화안정화제를 에이징하여 유화시키므로 Oil in Water(O/W) 타입-보습 영양 크림 화장료 조성물을 제조하는 제 4 단계에 따라 제조될 수 있다.The Oil in Water (O/W) type moisturizing nourishing cream of the present invention is characterized in that it is prepared by emulsifying the aqueous phase component and the oil phase component, and the first step of preparing the aqueous phase component by dissolving the active ingredient in a water-soluble solvent; A second step of preparing an oil component; A third step of mixing the aqueous phase component, oil phase component and emulsion stabilizer; And it can be prepared according to the fourth step of preparing an Oil in Water (O / W) type-moisturizing nutritious cream cosmetic composition by aging and emulsifying the mixed aqueous phase component, oil phase component and emulsion stabilizer.
상기 수상성분은 봉독 추출물, 식물성 플라센타, sh-올리고펩타이드-1, 히알루론산, 정제수, 글리세린, 및 부틸렌글리콜을 포함하는 것을 특징으로 하며; 상기 유상 성분은 동물성 오일인 마유, 에뮤오일, 및 라놀린과 식물성 오일인 렉스필 오일 및 MCT 오일을 포함하는 것을 특징으로 하고; 상기 유화안정화제는 이멀시파잉 왁스, 세테아릴알코올, 올리브유 왁스 및 에틸헥산을 포함하는 것을 특징으로 한다. 추가적으로 상기 동물성 오일은 밍크오일, 스쿠알란, 난황유, 또는 거북유가 더 사용될 수 있으며; 상기 유화안정화제는 몬타왁스, 비즈왁스, 레시틴, 또는 칸델릴라왁스가 더 사용될 수 있다.The aqueous phase component is characterized in that it includes bee venom extract, vegetable placenta, sh-oligopeptide-1, hyaluronic acid, purified water, glycerin, and butylene glycol; The oily component is characterized in that it includes horse oil, emu oil, and lanolin, which are animal oils, and rexfil oil and MCT oil, which are vegetable oils; The emulsion stabilizer is characterized by including emulsifying wax, cetearyl alcohol, olive oil wax and ethylhexane. Additionally, as the animal oil, mink oil, squalane, egg yolk oil, or tortoise oil may be further used; Monta wax, beeswax, lecithin, or candelilla wax may be further used as the emulsion stabilizer.
본 발명의 Oil in Water(O/W) 타입-보습 영양크림은 상기 수상성분과 상기 유상성분이 2.7 내지 3.0:1의 중량비로 혼합되어 제조되는 것을 특징으로 하며 상기 유화안정화제와 유상성분은 0.1 내지 2:1(유화안정화제:유상성분) 중량비로 포함되는 것을 특징으로 한다.The Oil in Water (O/W) type moisturizing nourishing cream of the present invention is characterized in that the aqueous phase component and the oil phase component are mixed in a weight ratio of 2.7 to 3.0: 1, and the emulsion stabilizer and oil phase component are 0.1 to 2: 1 (emulsion stabilizer: oil component) characterized in that it is included in a weight ratio.
상기 수상성분과 상기 유상성분이 2.7:1(수상성분:유상성분)의 중량비 미만으로 혼합되면 Oil in Water(O/W) 타입 유화가 아닌 Water in Oil(W/O) 타입 유화가 동시에 일어날 수 있으며 유화를 위하여 유화안정화제를 더 사용하여야 하는 문제점이 있다. 상기 수상성분과 상기 유상성분이 3:1(수상성분:유상성분)의 중량비를 초과하며 혼합되더라도 Oil in Water(O/W) 타입 유화정도는 더 향상되지 않을 뿐 아니라 유상성분의 부족으로 점도가 낮아져 발림성이 저하되며, 피부조직을 이루는 지방산 구조와 유사한 유상성분의 함량감소로 상기 유효성분들의 침투성과 피부 보습성이 저하된다.When the water phase component and the oil phase component are mixed at a weight ratio of less than 2.7: 1 (aqueous component: oil component), water in oil (W/O) type emulsification, not oil in water (O/W) type emulsification, may occur at the same time. And there is a problem that more emulsion stabilizers should be used for emulsification. Even if the aqueous phase component and the oil phase component are mixed in a weight ratio of more than 3:1 (aqueous phase component:oil component), the degree of emulsification of the Oil in Water (O/W) type is not further improved, and the viscosity is increased due to the lack of oil phase component. It lowers the spreadability, and the permeability and skin moisturizing properties of the active ingredients decrease due to the decrease in the content of oily components similar to the fatty acid structure constituting the skin tissue.
본 발명의 il in Water(O/W) 타입-보습 영양크림은 상기 봉독 추출물, 식물성 플라센타, sh-올리고펩타이드-1 및 히알루론산이 1:1:1:1로 포함된 수상성분과 상기 동물성 오일과 식물성 오일이 1.8 내지 2.2:1의 중량비로 포함된 유상성분을 포함하는 것을 특징으로 한다. 상기 동물성 오일은 피부조직을 이루는 지방산과 매우 유사한 구조를 가지므로 상기 봉독 추출물, 식물성 플라센타, sh-올리고펩타이드-1의 피부침투력을 향상시키는 효과가 있다. 그러나 상기 동물성 오일은 온도에 따른 점도의 변화가 심하여 보관이 어려운 단점이 있다. 본 발명에서는 이를 보완하기 위하여 보다 안정적인 식물성 오일을 더 포함하여 제조하며 그 최적의 혼합비율로서 동물성 오일과 식물성 오일을 1.8 내지 2.2:1의 중량비로 포함하는 것을 특징으로 한다.The il in Water (O/W) type-moisturizing nutrient cream of the present invention contains the aqueous ingredients containing the bee venom extract, plant placenta, sh-oligopeptide-1 and hyaluronic acid in a ratio of 1:1:1:1 and the animal oil. and vegetable oils in a weight ratio of 1.8 to 2.2: 1. Since the animal oil has a structure very similar to fatty acids constituting skin tissue, it has an effect of improving the skin penetration of the bee venom extract, vegetable placenta, and sh-oligopeptide-1. However, the animal oil has a disadvantage in that it is difficult to store due to a severe change in viscosity according to temperature. In the present invention, to compensate for this, more stable vegetable oil is further included, and the optimal mixing ratio is characterized by including animal oil and vegetable oil in a weight ratio of 1.8 to 2.2: 1.
본 발명의 Oil in Water(O/W) 타입-보습 영양 크림 화장료 조성물은 상기 제조방법에 따라 유화되면 에멀젼의 내부로 수상의 유효성분이 위치하게 되고 에멀젼의 외부로 유성의 오일층이 둘러싸게 된다. 이때 에멀젼의 내부를 구성하는 수상의 유효성분과 에멀젼의 외부를 구성하는 동물성 오일의 구성비에 따라 피부침투력 및 에멀젼의 안정성이 결정된다. 본 발명의 Oil in Water(O/W) 타입-보습 영양 크림 화장료 조성물은 수상성분의 봉독 추출물, 식물성 플라센타, sh-올리고펩타이드-1 및 히알루론산과 상기 유상 성분의 동물성 오일이 0.6 내지 1:1의 중량비로 포함된 것을 특징으로 한다. 상기 중량비가 0.6:1 미만이면 Oil in Water(O/W) 타입 에멀젼의 형성이 어려울 수 있으며 에멀젼이 형성되더라도 피부침투력이 저하될 수 있으며 상기 중량비가 1:1을 초과하더라도 피부 침투력인 더 증가하지 않는다.When the oil in water (O/W) type-moisturizing nutritious cream cosmetic composition of the present invention is emulsified according to the above manufacturing method, the active ingredients of the water phase are located inside the emulsion and the oily oil layer is surrounded outside the emulsion. At this time, the skin penetration ability and stability of the emulsion are determined according to the composition ratio of the active ingredient of the aqueous phase constituting the inside of the emulsion and the animal oil constituting the exterior of the emulsion. The Oil in Water (O/W) type-moisturizing and nutritious cream cosmetic composition of the present invention contains bee venom extract, vegetable placenta, sh-oligopeptide-1, and hyaluronic acid as water-phase components and animal oil as oil-phase components in a ratio of 0.6 to 1:1. It is characterized in that included in the weight ratio of. If the weight ratio is less than 0.6: 1, it may be difficult to form an Oil in Water (O / W) type emulsion, and even if the emulsion is formed, skin penetration may be reduced, and even if the weight ratio exceeds 1: 1, skin penetration is not further increased. don't
본 발명의 Oil in Water(O/W) 타입-보습 영양크림은 점도가 21000 내지 24000dPa·S이며 도포 12시간 후 수분함량이 50 내지 55%인 것을 특징으로 한다. 상기 점도가 21000dPa·S미만이면 너무 묽어 흘러내리므로 반복적이 사용에 제한이 있을 수 있으며 도포 12시간 후 수분함량이 50%미만으로 수분유지효과가 저하될 수 있다. 또한 상기 점도가 24000dPa·S를 초과하게 되면 끈적임이 과도하거나 푸석거리는 느낌이 강하여 발림성이 저하되는 문제점이 있다. The Oil in Water (O/W) type moisturizing nutrient cream of the present invention has a viscosity of 21000 to 24000 dPa·S and a water content of 50 to 55% after 12 hours of application. If the viscosity is less than 21000 dPa·S, it is too thin and flows down, so repeated use may be limited, and the water content may be reduced to less than 50% after 12 hours of application. In addition, when the viscosity exceeds 24000 dPa·S, there is a problem in that the application property is deteriorated due to excessive stickiness or a strong crumbly feeling.
하기에서 실시예를 통하여 본 발명을 상세히 설명한다.The present invention will be described in detail through examples below.
실시예 Example
실시예 : 보습 영양크림Example: Moisturizing and nourishing cream
1. 재료1. Materials
본 발명의 화장료 조성물은 보습 영양크림 화장료 조성물이다. 본 발명은 수상유효성분으로서 바이오 플라센타, 봉독펩타이드, 나노 올리고펩타이드 및 저분자 소듐히알루로네이트를 사용하였다. 상기 바이오 플라센타는 콩에서 유래한 소이 피토플라센타(Soy Phytoplacenta) 추출물이며 피부 및 헤어 컨디셔닝용을 제조된 원료물질을 사용하였다. 상기 봉독펩타이드는 정제수, 부틸렌글라이콘, 및 페녹시에탄올을 포함하는 용매에 봉독펩타이드가 0.1%(1000ppm)으로 녹아있는 용액을 사용하였다. 상기 sh-올리고펩타이드-1은 합성 인간 상피세포 성장인자-1(Synthetic Human Epidermal Growth Factor, sh-EGF)이며 글리세린, 1,3-부틸렌글리콜, 및 1,2-헥산디올을 포함하는 용매에 상기 sh-EGF가 0.0001%로 용해된 용액을 사용하였다. 상기 저분자 소듐히알루로네이트(oligo-Sodium Hyaluronic acid)로 분자량이 10KDa이하이며 정제수, 부틸렌글리콜, 1,2-헥산디올을 포함하는 용매에 1wt%로 용해된 용액을 사용하였다. 상기 수상유효성분은 정제수, 글리세린(Glycerin), 및 부틸렌글리콜(Butylene Glycol)을 포함하는 용매에 녹여 사용하였다. The cosmetic composition of the present invention is a moisturizing and nourishing cream cosmetic composition. In the present invention, bio placenta, bee venom peptide, nano oligopeptide and low molecular weight sodium hyaluronate were used as aqueous phase active ingredients. The bioplacenta is a soy phytoplacenta extract derived from soybeans, and raw materials prepared for skin and hair conditioning were used. For the bee venom peptide, a solution in which 0.1% (1000 ppm) of the bee venom peptide was dissolved in a solvent containing purified water, butylene glycol, and phenoxyethanol was used. The sh-oligopeptide-1 is synthetic human epidermal growth factor-1 (Synthetic Human Epidermal Growth Factor, sh-EGF) and is prepared in a solvent containing glycerin, 1,3-butylene glycol, and 1,2-hexanediol. A solution in which the sh-EGF was dissolved at 0.0001% was used. As the low molecular weight sodium hyaluronate (oligo-Sodium Hyaluronic acid), a solution having a molecular weight of 10 KDa or less and dissolved in a solvent containing purified water, butylene glycol, and 1,2-hexanediol at 1 wt% was used. The aqueous phase active ingredient was used after being dissolved in a solvent containing purified water, glycerin, and butylene glycol.
본 발명은 유상성분으로서 동물성 오일인 마유(Horse oil), 에뮤오일(Emu Oil), 라놀린(Lanolin)을 사용하였으며 식물성 오일인 렉스필 오일 및 MCT 오일을 사용하였다. In the present invention, horse oil, emu oil, and lanolin, which are animal oils, were used as oily components, and vegetable oils, Rexpil Oil and MCT Oil, were used.
본 발명은 수상성분과 유상성분의 원활한 유화를 위하여 유화안정제로서 이멀시파잉 왁스, 올리브유 왁스, 세테아릴알코올 및 에틸헥산을 사용하였으며 방부제로서 1,2-헥산디올을 사용하였다.In the present invention, emulsifying wax, olive oil wax, cetearyl alcohol and ethylhexane were used as emulsion stabilizers for smooth emulsification of aqueous and oil components, and 1,2-hexanediol was used as a preservative.
2. 보습 영양크림의 제조법2. Manufacturing method of moisturizing and nourishing cream
정제수 30g, 글리세린 2g, 및 부틸렌 글리콜 3g을 혼합하여 수상혼합용액을 제조하였다. 상기 수상혼합용액에 1% sh-올리고펩타이드-1(sh-Oligopeptide-1, 1% OLIGO-HA(HD))) 1g, 콩 유래 피토플라센타(Soybean Phytoplacenta) 추출물 1g, 0.1% 봉독펩타이드(Bee Venom Extract) 1g 및 1% 소듐히랄루로네이트(Sodium Hyaluronate) 1g을 첨가하고 100rpm에서 3분간 교반하여 수상 유효성분 혼합액을 제조하였다.An aqueous mixed solution was prepared by mixing 30 g of purified water, 2 g of glycerin, and 3 g of butylene glycol. 1g of 1% sh-Oligopeptide-1 (1% OLIGO-HA (HD)), 1g of soybean phytoplacenta extract, 0.1% bee venom peptide (Bee Venom Extract) and 1% sodium hyaluronate (Sodium Hyaluronate) 1g was added and stirred at 100 rpm for 3 minutes to prepare a water phase active ingredient mixture.
마유(Horse Oil) 4g, 에뮤오일(Emu Oil) 4g, 이멀시파잉왁스(Emulsifying Wax) 3.5g. 세테아릴알코올(Cetearyl Alcohol), 3.8g, 올리브유 왁스(Olive Oil Wax) 4g, 라놀린(Lanolin) 2g, 렉스필 오일(Lexfeel Oil, Heptyl Undecylenate) 2g, MCT(Medium Chain Triglycerides) 오일 3g, 에틸헥실글리세린(Ethylhexylglycerin) 0.2g, 및 1,2-헥산디올(1,2-Hexanediol) 1.5g을 혼합하여 유상 혼합용액을 제조하였다.Horse Oil 4g, Emu Oil 4g, Emulsifying Wax 3.5g. Cetearyl Alcohol, 3.8g, Olive Oil Wax 4g, Lanolin 2g, Lexfeel Oil (Heptyl Undecylenate) 2g, Medium Chain Triglycerides (MCT) Oil 3g, Ethylhexyl An oily mixed solution was prepared by mixing 0.2 g of glycerin (Ethylhexylglycerin) and 1.5 g of 1,2-hexanediol.
상기 수상 유효성분 혼합액과 유상 혼합용액을 각각 온도를 70℃까지 올려 100rpm에서 1분간 교반하므로 상기 수상 유효성분 혼합액과 유상 혼합용액의 구성물을 완전히 용해시킨 후 65℃를 유지하며 더 혼합시켰다.The aqueous phase active ingredient mixture and the oil phase mixture were heated to 70 ° C. and stirred at 100 rpm for 1 minute, so that the components of the aqueous phase active ingredient mixture and the oil phase mixture were completely dissolved and further mixed while maintaining the temperature at 65 ° C.
상기 65℃로 유지된 수상 유효성분 혼합액과 유상 혼합용액을 혼합하고 5000rpm에서 1분간 1차 교반하고 이어서 200rpm에서 2분간 2차 교반하여 유화(Emulsifying)시켜 유화액을 제조하였다.An emulsion was prepared by mixing the aqueous phase active ingredient mixture and the oil phase mixture solution maintained at 65° C., first stirring at 5000 rpm for 1 minute, and then secondarily stirring at 200 rpm for 2 minutes to emulsify.
상기 유화액은 40℃까지 급냉각한 후 120rpm에서 30분간 시효처리(aging)를 수행하였다.The emulsion was rapidly cooled to 40° C. and then aged at 120 rpm for 30 minutes.
상기 40℃에서 시효처리된 유화액을 30℃로 냉각 한 후 첨가물을 더 첨가한 후 200rpm에서 1분간 혼합하여 보습 영양 크림을 제조하였다. 상기 첨가물은 참마뿌리추출물, 알로에베라잎 추출물, 마치현 추출물, 어성초추출물, 삼백초 추출물, 병풀추출물, 라벤더 에센셜 오일, 띠뿌리 추출물(mperata Cylindrica root extract), D-판테놀, 및 천연소포제(BST-AF)을 사용하였다. 상기 첨가물을 혼합한 후 상기 냉각 및 혼합온도를 30℃ 이상으로 하게 되면 추출물의 분해 및 부패가 빠르게 진행될 수 있다. After cooling the emulsion aged at 40 ° C to 30 ° C, additional additives were added, and then mixed at 200 rpm for 1 minute to prepare a moisturizing and nourishing cream. The additives are yam root extract, aloe vera leaf extract, Portulaca extract, Houttuynia cordata extract, Sambaekcho extract, centella asiatica extract, lavender essential oil, strip root extract (mperata Cylindrica root extract), D-panthenol, and natural antifoaming agent (BST-AF) was used. After mixing the additives, when the cooling and mixing temperature is set to 30° C. or higher, the decomposition and decay of the extract may proceed rapidly.
상기 보습 영양 크림은 상기 수상 유효성분 혼합액에 포함되는 1% sh-올리고펩타이드-1(sh-Oligopeptide-1, 1% OLIGO-HA(HD))), 콩유래 피토플라센타(Soybean Phytoplacenta) 추출물, 0.1% 봉독펩타이드(Bee Venom Extract) 및 1% 소듐히랄루로네이트(Sodium Hyakuronate)의 양을 달리하여 하기와 같이 제조하였다.The moisturizing and nutritious cream contains 1% sh-Oligopeptide-1 (1% OLIGO-HA (HD)), soybean-derived phytoplacenta extract, 0.1 It was prepared as follows by varying the amount of % Bee Venom Extract and 1% Sodium Hyakuronate.
실험예 1: 적외선 스펙트럼 분석Experimental Example 1: Infrared spectrum analysis
본 발명의 유효성분이 O/W type(Oil In Water)으로 제조되었는지 확인하기 위하여 본 발명의 보습 영양 크림에 대하여 적외선 스펙트럼 분석(TENSOR27, Bruker)을 수행하였다. 상기 적외선 스펙트럼 분석은 4500nm까지 스캔하였다. 그 결과 1500 내지 1800nm 영역에서 2개의 피크, 3000nm 및 3300nm 부근에서 각각 피크가 확인되어 상기 유효성분을 포함하는 보습 영양 크림이 O/W type으로 제조되었다는 것을 확인하였다(도 1 참조).Infrared spectrum analysis (TENSOR27, Bruker) was performed on the moisturizing and nourishing cream of the present invention to confirm whether the active ingredient of the present invention was manufactured as an O/W type (Oil In Water). The infrared spectrum analysis was scanned up to 4500 nm. As a result, two peaks in the 1500 to 1800 nm region and peaks around 3000 nm and 3300 nm were confirmed, respectively, confirming that the moisturizing and nourishing cream containing the active ingredient was prepared in an O / W type (see FIG. 1).
실험예 2: 점도 및 수분-보습 평가Experimental Example 2: Evaluation of viscosity and moisture-moisturization
상기 제조한 실시예 1, 2, 3, 및 4의 보습 영양 크림에 대하여 VT-60점도계(25℃)를 이용한 점도를 측정하였다. 또한 JASKEY 피부 유수분측정기를 이용하여 수분 및 보습 테스트를 수행하였다. The viscosity of the moisturizing and nourishing creams of Examples 1, 2, 3, and 4 prepared above was measured using a VT-60 viscometer (25° C.). In addition, moisture and moisturizing tests were performed using a JASKEY skin oil and moisture meter.
상기 피부 유수분 측정은 숙련된 피 실험자 4명(30대 여성 1명, 30대 남성 1명, 60대 여성 1명, 40대 여성 1명)에 대하여 실시하였다. 먼저 피 실험자는 각 제품을 바르기 전 물로 세안 진행하고 세안 1분 후 유수분을 측정하였다. 그 후 본 발명의 보습 영양 크림을 고르게 도포 한 뒤 1시간, 6시간, 12시간 마다 유수분을 측정하고 평균값을 산출하였다.The skin oil and moisture measurement was performed on 4 experienced test subjects (1 female in her 30s, 1 male in her 30s, 1 female in her 60s, and 1 female in her 40s). First, the test subjects washed their face with water before applying each product, and after 1 minute of washing, the oil and moisture content was measured. After that, the moisturizing and nourishing cream of the present invention was applied evenly, and the oil and moisture content was measured every 1 hour, 6 hours, and 12 hours, and the average value was calculated.
(VT-06)Viscosity
(VT-06)
실험결과, 제품의 발림성은 실시예 2 및 3의 크림이 가장 우수한 발림성을 가지는 것으로 확인되었으며 점도는 2000 내지 22000dPa·S이었다. 실시예 1의 크림은 발림시 푸석거리는 경향이 강한 것으로 확인되었으며 실시예 4의 크림은 성상이 너무 묽어 발림시 흘러내리는 경향이 있는 것으로 확인되었다. As a result of the experiment, it was confirmed that the creams of Examples 2 and 3 had the best spreadability, and the viscosity was 2000 to 22000 dPa·S. The cream of Example 1 was confirmed to have a strong tendency to crumbly when applied, and the cream of Example 4 was confirmed to have a tendency to flow when applied due to its too watery properties.
수분 보습 평가 결과 실시예 1, 3, 및 4는 도포 후 12시간이 경과하면 크림의 도포로 인하여 증가하였던 수분함량이 13%가량 줄어드는 반면 실시예 2의 경우 도포 후 12시간이 경과하여도 수분함량의 감소가 10% 미만인 것으로 확인되었다. 또한 실시예 1, 3, 및 4의 경우 도포 후 1시간이 경과한 경우 수분함량이 급격히 감소(8% 이상 감소)한 후 시간에 따라 완만히 감소하는 경향을 보이나 실시예 2의 경우 시간에 상관없이 완만한 수분 감소를 보이는 것으로 확인되었다. As a result of evaluation of moisture retention, in Examples 1, 3, and 4, the moisture content, which increased due to the application of the cream, decreased by about 13% when 12 hours elapsed after application, whereas in Example 2, even after 12 hours after application, the moisture content A reduction of less than 10% was found. In addition, in the case of Examples 1, 3, and 4, when 1 hour elapsed after application, the moisture content rapidly decreased (reduction by 8% or more) and then gradually decreased with time, but in the case of Example 2, regardless of time It was confirmed that there was a gradual decrease in moisture.
상기 결과는 본 발명의 실시예 2가 유상성분, 수상성분 및 유화안정화제의 비율이 최적화 되어 있음 뿐 아니라 유화방법에 있어서도 최적화되어 있으므로 크림에 존재하는 동물성 및 식물성 오일 성분과 수상유효성분이 매우 균질하게 분산되어 있어 수분의 감소 속도를 일정하게 유지시킨 결과인 것으로 판단된다(도 2 참조).The above results show that in Example 2 of the present invention, the proportions of oil phase components, aqueous phase components, and emulsion stabilizers are optimized, as well as the emulsification method, so that animal and vegetable oil components present in the cream and active ingredients in the water phase are very homogeneous. It is determined that it is the result of maintaining a constant rate of reduction of moisture because it is dispersed (see FIG. 2).
실험예 3: 제품 만족도 평가Experimental Example 3: Product Satisfaction Evaluation
본 발명의 실시예 중 발림성 및 수분보습효과가 가장 우수한 실시예 2에 대하여 제품 성능에 대한 만족도 평가를 수행하였다. 이를 위하여 남성 실험자 및 여성 실험자 각 8명을 선별하였다. 상기 실험자를 연력에 따라 분류하면 20대 2명, 30대 12명, 50대 1명, 및 60대 1명이었으며 피부특성에 따라 분류하면 건성 피부타입 5명, 지성 피부타입 3명 및 복합피부타입 8명의 구성이었다. Among the examples of the present invention, the evaluation of satisfaction with product performance was performed for Example 2, which had the best spreadability and moisture moisturizing effect. For this purpose, 8 male and female testers were selected. When the experimenters were classified according to age, there were 2 people in their 20s, 12 people in their 30s, 1 person in their 50s, and 1 person in their 60s. When classified according to skin characteristics, there were 5 dry skin types, 3 oily skin types, and combination skin types. It was a composition of 8 people.
제품 성능 평가는 상기 실험자가 총 4주간 직접 사용하면서 수분 및 보습 성능, 피부 안정성 성능, 피부 영양 성능, 흡수력 성능, 텍스쳐 성능 및 만족도 항목을 주관적으로 평가하는 방법으로 수행하였다. Product performance evaluation was performed by subjectively evaluating moisture and moisturizing performance, skin stability performance, skin nutrition performance, absorption performance, texture performance and satisfaction items while the experimenter directly used it for a total of 4 weeks.
상기 수분 및 보습(Moisture) 성능은 수분 및 보습 효과가 우수하여 피부의 촉촉함이 오랜 시간 유지되는 성능을 의미하며 실험자가 4주간 사용하면서 상기 성능에 대하여 주관에 따라 아주 만족하는 경우 5점, 만족하는 경우 4점, 보통인 경우 3점, 미흡한 경우 2점, 아주 미흡한 경우 1점을 주도록 하였다.The moisture and moisture performance means that the moisture and moisture effect is excellent, so that the moisture of the skin is maintained for a long time, and when the experimenter is very satisfied with the performance according to subjective use while using it for 4 weeks, 5 points are satisfied. 4 points for good, 3 points for moderate, 2 points for poor, and 1 point for very poor.
상기 피부 안정성(Skin Care) 성능은 크림의 사용으로 인한 피부염, 좁쌀 여드름, 화농성 여드름, 부위별 여드름을 포함하는 피부 트러블이 발생하지 않거나 상기 피부 트러블이 감소하는 것을 의미하며 실험자가 4주간 사용하면서 상기 성능에 대하여 주관에 따라 아주 만족하는 경우 5점, 만족하는 경우 4점, 보통인 경우 3점, 미흡한 경우 2점, 아주 미흡한 경우 1점을 주도록 하였다.The skin care performance means that skin troubles, including dermatitis, acne, purulent acne, and site-specific acne, due to the use of the cream do not occur or that the skin troubles are reduced, and the experimenter uses the cream for 4 weeks. Performance was rated 5 points for very satisfied, 4 points for satisfactory, 3 points for average, 2 points for poor performance, and 1 point for very poor performance.
본 발명의 영양 크림의 주된 유효성분인 봉독과 식물 플라센타는 주름개선효과, 외부자극 보호 효과, 진정효과, 피부탄력 유지효과, 피부 혈액순환 촉진 효과, 피부 노폐물 제거효과, 영양공급 효과, 및 피부 수분 유지효과가 있다. 따라서 상기 피부 영양(Nutrition) 성능은 실험자가 4주간 사용하면서 상기 유효성분의 효과에 대하여 주관에 따라 아주 만족하는 경우 5점, 만족하는 경우 4점, 보통인 경우 3점, 미흡한 경우 2점, 아주 미흡한 경우 1점을 주도록 하였다.Bee venom plant placenta, the main active ingredient of the nourishing cream of the present invention, has wrinkle improvement effect, external stimulation protection effect, soothing effect, skin elasticity maintenance effect, skin blood circulation promotion effect, skin waste removal effect, nutrient supply effect, and skin moisture There is a maintenance effect. Therefore, the skin nutrition performance was 5 points if the experimenter was very satisfied with the effect of the active ingredient while using it for 4 weeks, 4 points if satisfied, 3 points if normal, 2 points if insufficient, and very 1 point was given if it was insufficient.
상기 흡수력(Absorptivity) 성능은 크림의 사용 시 크림이 피부에 잘 흡수되어 발림성이 우수한 것을 의미하며 상기 성능에 대하여 주관에 따라 아주 만족하는 경우 5점, 만족하는 경우 4점, 보통인 경우 3점, 미흡한 경우 2점, 아주 미흡한 경우 1점을 주도록 하였다.The absorptivity performance means that the cream is well absorbed into the skin and has excellent spreadability when using the cream, and for the above performance, 5 points for very satisfied, 4 points for satisfactory, 3 points for average, A score of 2 was given for poor and 1 point for very poor.
상기 텍스쳐(Texture) 성능은 크림이 피부에 도포된 경우 미세한 요철등과 같은 표면 상태의 질감을 의미하며 발림성이 우수하고 피부에 잘 흡수되어 질감이 우수한 경우 주관에 따라 아주 만족하는 경우 5점, 만족하는 경우 4점, 보통인 경우 3점, 미흡한 경우 2점, 아주 미흡한 경우 1점을 주도록 하였다The texture performance refers to the texture of the surface state such as fine irregularities when the cream is applied to the skin, and if the texture is excellent because it is well applied and absorbed into the skin, 5 points if the cream is very satisfied according to the subjective, Satisfied 4 points for good, 3 points for average, 2 points for poor, and 1 point for very poor
상기 만족도는 상기 수분 및 보습 성능, 피부 안정성 성능, 피부 영양 성능, 흡수력 성능, 및 텍스쳐 성능을 전체적으로 고려하였을 때 얼마나 만족하는 지에 대한 것으로 아주 만족하는 경우 5점, 만족하는 경우 4점, 보통인 경우 3점, 미흡한 경우 2점, 아주 미흡한 경우 1점을 주도록 하였다.The satisfaction is about how satisfied you are when considering the moisture and moisturizing performance, skin stability performance, skin nutrition performance, absorption performance, and texture performance as a whole, 5 points for very satisfied, 4 points for satisfactory, and average. 3 points, 2 points for poor, and 1 point for very poor.
본 발명의 영양 크림에 대한 수분 및 보습 성능, 피부 안정성 성능, 피부 영양 성능, 흡수력 성능, 텍스쳐 성능, 및 만족도 평가 결과는 하기 표 3과 같다. The moisture and moisturizing performance, skin stability performance, skin nutrition performance, absorption performance, texture performance, and satisfaction evaluation results for the nutritional cream of the present invention are shown in Table 3 below.
만족도 평가 결과 전체적인 만족도가 평균 4.3점으로 우수 만족도 기준인 4점을 넘어 우수한 만족도를 보이는 것으로 확인되었다. 수분 및 보습 성능 및 텍스쳐 성능에 대한 만족도가 4.4점으로 가장 높았으며 흡수력 성능의 만족도 점수가 3.9점으로 가장 낮았으나 77.5%의 실험자가 흡수력 성능을 우수 이상으로 평가한 것으로 보아 제품의 품질에 큰 문제점은 없는 것으로 판단되었다. As a result of the satisfaction evaluation, it was confirmed that the overall satisfaction was 4.3 points on average, showing excellent satisfaction beyond the excellent satisfaction standard of 4 points. Satisfaction with moisture and moisturizing performance and texture performance was the highest at 4.4 points, and the satisfaction score for absorption performance was the lowest at 3.9 points. was judged to be absent.
본 명세서에서 설명된 구체적인 실시예는 본 발명의 바람직한 구현예 또는 예시를 대표하는 의미이며, 이에 의해 본 발명의 범위가 한정되지는 않는다. 본 발명의 변형과 다른 용도가 본 명세서 특허청구범위에 기재된 발명의 범위로부터 벗어나지 않는다는 것은 당업자에게 명백하다. Specific examples described in this specification are meant to represent preferred embodiments or examples of the present invention, and the scope of the present invention is not limited thereby. It will be apparent to those skilled in the art that variations and other uses of the present invention do not depart from the scope of the invention described in the claims.
Claims (6)
Oil in Water (O/W) type containing Bee Venom Extract, Vegetable Placenta, sh-Oligopeptide-1 and Hyaluronic acid - moisturizing nutrition Cream cosmetic composition.
The oil in water (O/W) type of claim 1, wherein the oil-in-water (O/W) type-moisturizing nourishing cream is prepared by mixing water-phase components and oil-phase components in a weight ratio of 2.7 to 3.0: 1. Type - Moisturizing and nourishing cream cosmetic composition.
The oil in water (O/W) type moisturizing nutrient cream according to claim 2, wherein the water-phase component consisting of bee venom extract, vegetable placenta, sh-oligopeptide-1, hyaluronic acid, purified water, glycerin, and butylene glycol and ; An oily component composed of animal oils such as horse oil, emu oil, and lanolin, and vegetable oils such as Rexpil Oil and MCT Oil; An Oil in Water (O/W) type-moisturizing nutritious cream cosmetic composition, characterized in that it is prepared by mixing emulsifying wax, cetearyl alcohol, olive oil wax and an emulsion stabilizer composed of ethylhexane.
4. The method of claim 3, wherein the aqueous phase component includes bee venom extract, vegetable placenta, sh-oligopeptide-1, and hyaluronic acid in a ratio of 1:1:1:1, and the oil phase component contains animal oil and vegetable oil in a ratio of 1.8 to 2.2:1. Oil in Water (O / W) type - moisturizing nutritious cream cosmetic composition, characterized in that contained in a weight ratio of.
The oil in water according to claim 3, characterized in that the aqueous phase component of bee venom extract, vegetable placenta, sh-oligopeptide-1 and hyaluronic acid and the oil phase component of animal oil are included in a weight ratio of 0.6 to 1:1 ( O/W) type-moisturizing nourishing cream cosmetic composition.
The Oil in Water (O/W) type-moisturizing nourishing cream according to claim 1, wherein the viscosity is 21000 to 24000 dPa S and the moisture content is 50 to 55% after 12 hours of application. W) A type-moisturizing nourishing cream cosmetic composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210088312A KR20230007680A (en) | 2021-07-06 | 2021-07-06 | Skin Moisturizing and Nutrition Cream Cosmetic Composition Containing Bee Veom Extract And Vegetable Placenta |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210088312A KR20230007680A (en) | 2021-07-06 | 2021-07-06 | Skin Moisturizing and Nutrition Cream Cosmetic Composition Containing Bee Veom Extract And Vegetable Placenta |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230007680A true KR20230007680A (en) | 2023-01-13 |
Family
ID=84900169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210088312A KR20230007680A (en) | 2021-07-06 | 2021-07-06 | Skin Moisturizing and Nutrition Cream Cosmetic Composition Containing Bee Veom Extract And Vegetable Placenta |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20230007680A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102613485B1 (en) * | 2023-03-23 | 2023-12-13 | 복영옥 | Natural cosmetic and manufacturing method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100118629A (en) | 2009-04-29 | 2010-11-08 | (주)아모레퍼시픽 | Cosmetic composition containing bee venom or extracts of the same |
KR20190035285A (en) | 2017-09-26 | 2019-04-03 | 부산대학교 산학협력단 | Connection unit for modular member and construction method of modular structure |
-
2021
- 2021-07-06 KR KR1020210088312A patent/KR20230007680A/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100118629A (en) | 2009-04-29 | 2010-11-08 | (주)아모레퍼시픽 | Cosmetic composition containing bee venom or extracts of the same |
KR20190035285A (en) | 2017-09-26 | 2019-04-03 | 부산대학교 산학협력단 | Connection unit for modular member and construction method of modular structure |
Non-Patent Citations (3)
Title |
---|
Journal of Integrative Medicine, 2013, Vol.11, No. 5, 320-326. |
Kor. J. Aesthet. Cosmetol., Vol. 13, No. 5, 679-688. |
Toxins 2015, 7, 4758-4772. |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102613485B1 (en) * | 2023-03-23 | 2023-12-13 | 복영옥 | Natural cosmetic and manufacturing method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111803425A (en) | High-permeability skin care composition, nano emulsion thereof and preparation method | |
KR20210043318A (en) | Skin cream cosmetic composition containing natural extract compound | |
KR102286990B1 (en) | Cosmetic composition comprising nanoemulsion containing bakuchiol as active ingredient | |
KR20230007680A (en) | Skin Moisturizing and Nutrition Cream Cosmetic Composition Containing Bee Veom Extract And Vegetable Placenta | |
RU2591789C1 (en) | Cosmetic composition for face and neck skin care | |
KR101096277B1 (en) | Cosmetic composition for moisturizing the skin | |
CN110522712A (en) | A kind of bad face maintenance essence and preparation method | |
KR20190142655A (en) | Cosmetic composition containg nanoemulsion encapsulated with 7-dehydrocholesterol, cholesterol and stearic acid in inner phase of hyaluronate-ceramide NP complex | |
KR102056116B1 (en) | Nano liquid crystal emulsion composition comprising natural extract and natural oil, and cosmetic composition comprising the same, and method for preparing same | |
CN105919886A (en) | Quick-acting wrinkle repairing emulsion and preparation method thereof | |
CN111529416A (en) | Powerful skin cleansing cream | |
KR102647764B1 (en) | Cosmetic composition containing vitamins | |
KR20210040522A (en) | Cosmetic composition, cosmetic mask pack comprisint the same and preperation method of the cosmetic composition | |
US20060134046A1 (en) | Skin nourishing and moisturizing cream | |
CN115337243A (en) | Blackhead removing composition and cosmetic | |
KR20190017420A (en) | Cosmetic compositions for improving skin moisturizing | |
KR100531980B1 (en) | Cosmetic composite containing a herb extract | |
KR100667182B1 (en) | Cosmetics for improvement xeroderma containing badger oil | |
KR101677546B1 (en) | Composition of sleeping type pack comprising MSM and snail secretion filtrate and manufacturing method thereof | |
KR20130060618A (en) | Mask composition with high coverage to skin | |
KR102071600B1 (en) | Cream composition manufacturing method for preventing of sensitive-skin and skin-trouble | |
KR20120138382A (en) | Pack composition | |
CN112137927A (en) | Fibronectin essence emulsion with high penetration and light sensation reproduction and tissue regeneration initiation and preparation method thereof | |
CN112245315A (en) | Ceramide facial mask with moisturizing and repairing effects and preparation method thereof | |
KR20200001146A (en) | Oil in Water Type Emulsified Cosmetic Composition Havung Low Stimulus And Preparation Method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |